Contrasting global methylation status between seminomatous and non-seminomatous male germ cell tumors

被引：0
|
作者：
Netto, G. J. [1 ]
Toubaji, A. [1 ]
Hicks, J. [1 ]
Jadallah, S. [1 ]
Epstein, J. I. [1 ]
DeMarzo, A. M. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
LABORATORY INVESTIGATION | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
793
引用
收藏
页码：173A / 174A
页数：2
相关论文
共 50 条
  • [41] Endoglin (CD105) expression in non-seminomatous germ cell tumors.
    Sikaria, Swati
    Chopra, Shefali
    Xiong, Shigang
    Yang, Dongyun
    Theuer, Charles P.
    Hu, James
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Association of KIT Mutations with Concurrent RAS/MAPK Pathway Driver Alterations in Seminomatous and Non-Seminomatous Germ-Cell Tumors
    Mata, Douglas
    Yang, Soo-Ryum
    Ferguson, Donna
    Liu, Ying
    Sharma, Rohit
    Al-Ahmadie, Hikmat
    Solit, David
    Feldman, Darren
    Tickoo, Satish
    Reuter, Victor
    Arcila, Maria
    Ladanyi, Marc
    Vanderbilt, Chad
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 931 - 933
  • [43] Brain metastasis from non-seminomatous germ cell tumors of the testisIndications for aggressive treatment
    Maurizio Salvati
    Manolo Piccirilli
    Antonino Raco
    Antonino Santoro
    Riccardo Frati
    Jacopo Lenzi
    Gaetano Lanzetta
    Antonino Agrillo
    Alessandro Frati
    Neurosurgical Review, 2006, 29 : 130 - 137
  • [44] COMPARISON OF 5 ONCODEVELOPMENTAL PROTEINS IN NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTES
    BRAUNSTEIN, GD
    THOMPSON, R
    MCINTIRE, KR
    CLINICAL RESEARCH, 1983, 31 (02): : A403 - A403
  • [45] Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors
    Oosting, S. F.
    de Haas, E. C.
    Links, T. P.
    de Bruin, D.
    Sluiter, W. J.
    de Jong, I. J.
    Hoekstra, H. J.
    Sleijfer, D. T.
    Gietema, J. A.
    ANNALS OF ONCOLOGY, 2010, 21 (01) : 104 - 108
  • [46] Non-seminomatous germ cell tumours [Nichtseminomatöse Keimzelltumoren]
    Bremmer F.
    Behnes C.L.
    Schweyer S.
    Der Pathologe, 2014, 35 (3): : 238 - 244
  • [47] DECREASING UTILIZATION OF RPLND FOR CLINICAL STAGE I NON-SEMINOMATOUS GERM CELL TUMORS
    Navai, Neema
    Shikanov, Sergey
    Pisters, Louis
    Eggener, Scott
    JOURNAL OF UROLOGY, 2012, 187 (04): : E305 - E305
  • [48] TUMOR-MARKERS IN PATIENTS WITH NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS
    WILLEMSE, PHB
    SLEIJFER, DT
    KOOPS, HS
    DEBRUIJN, HWA
    OOSTERHUIS, JW
    BROUWERS, TM
    OCKHUIZEN, T
    MARRINK, J
    ONCODEVELOPMENTAL BIOLOGY AND MEDICINE, 1981, 2 (1-2): : 117 - 128
  • [49] SEOM guidelines: non-seminomatous germ cell cancer (NSGCC)
    Maroto, Pablo
    Garcia del Muro, Xavier
    Sastre, Javier
    Isla, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (08): : 565 - 568
  • [50] Primary mediastinal non-seminomatous germ-cell tumors: From clinics to biology
    Fizazi, K
    Culine, S
    Droz, JP
    LeChevalier, T
    Ruffie, P
    Theodore, C
    BULLETIN DU CANCER, 1997, 84 (03) : 313 - 327
12345